Skip to content

Released Oct 27, 2016, after the close

10-Q filed Oct 28, 2016, 28 days after period end · 0000917520-16-000100

Q3 2016 · 10-Q
Revenue$250.33M+10.6% vs Q3 2015+0.4% vs Q2 2016
Net Income$20.14MN/M vs Q3 2015+57.9% vs Q2 2016
EPS Diluted$0.25N/M vs Q3 2015+56.3% vs Q2 2016
Gross Profit$161,003,000+14.8%
Operating Income$30,095,000+201.1%
Operating Cash Flowderived$46,767,000+138.5%
Free Cash Flowderived$39,793,000+179.2%
Margins · derived
Gross margin64.3%+2.3 pt vs Q3 2015
Operating margin12.0%+7.6 pt vs Q3 2015
Net margin8.0%+22.1 pt vs Q3 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2016Q3 2015Q3 2014Q3 2013
Revenue$250.33M$226.37M$197.52M$213.25M
Net Income$20.14M-$31.88M$9.81M-$30.33M
EPS Diluted$0.25-$0.45$0.30-$1.09

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR